Search our Database of Scientific Publications and Authors

I’m looking for a
    Carcinoid Syndrome and Carcinoid Heart Disease as Manifestations of Non-Metastatic Ovarian Neuroendocrine Tumour.
    Acta Med Port 2017 May 31;30(5):421-425. Epub 2017 May 31.
    Oxford Centre for Diabetes, Endocrinology and Metabolism. Churchill Hospital. Oxford. United Kingdom.
    The carcinoid syndrome is rare but it is associated with carcinoid heart disease in more than a half of the cases. Carcinoid heart disease is typically characterised by morphological and functional modifications of right-sided valves. Its aetiology is probable multifactorial but serotonin appears to play a key role in the development of this valvular disease. Unlike gastrointestinal neuroendocrine tumours, ovarian neuroendocrine tumours can present with carcinoid syndrome and carcinoid heart disease in the absence of liver metastases; such ovarian neuroendocrine tumours are a unique clinical entity. The additional burden of cardiac impairment in these patients represents a significant reduction in survival. Early recognition and surgical valve replacement before advanced heart failure is established may improve the clinical outcome. We report the case of a woman with an ovarian neuroendocrine tumour and highly symptomatic carcinoid heart disease who was submitted to tumour resection followed by valvuloplasty. She demonstrated an outstanding clinical improvement and has remained free of tumour and symptomatology.

    Similar Publications

    Carcinoid Heart Disease without Liver Involvement Caused by a Primary Ovarian Carcinoid Tumour.
    Heart Lung Circ 2015 Jul 24;24(7):e97-e100. Epub 2015 Feb 24.
    Icahn School of Medicine, Mount Sinai Medical Center, NY, USA.
    Carcinoid heart disease, caused by primary ovarian carcinoid tumour, is a rare form of valvular heart disease. This form of heart disease usually presents with symptoms of right-sided valvular dysfunction, ultimately leading to right-sided heart failure. This entity is unique as it develops in the absence of liver metastasis. Read More
    Resolution of right-sided heart failure symptoms after resection of a primary ovarian carcinoid tumor.
    Tex Heart Inst J 2014 Oct 1;41(5):533-6. Epub 2014 Oct 1.
    Carcinoid tumors are rare neuroendocrine malignancies that typically originate from the gastrointestinal tract. Patients who are diagnosed with carcinoid heart disease generally have poor prognoses because of advanced metastases during staging and few therapeutic options. We present the case of a 61-year-old woman with right-sided heart failure, secondary to carcinoid heart disease caused by a primary ovarian carcinoid tumor. Read More
    Hepatic surgery for metastases from neuroendocrine tumors.
    Surg Oncol Clin N Am 2003 Jan;12(1):231-42
    Division of Gastroenterologic and General Surgery, Mayo Clinic, Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA.
    Cytoreductive therapy is effective in the management of metastatic neuroendocrine tumors to the liver, independent of their functioning status. In functioning tumors, clinical endocrinopathies are relieved in most patients and this response usually lasts for several months. Major morbidity and mortality are not greater than the average complication rate for resection for nonneuroendocrine metastatic tumors at major centers; therefore, surgical outcomes appear to justify operative intervention. Read More